> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments on PDMA Information Collection Extension
- URL: https://www.fdaweb.com/comments-on-pdma-information-collection-extension/
- Published: 2017-12-14T12:00:00.000Z
- Updated: 2026-09-14T23:08:52.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5140345

*Federal Register* notice: FDA is seeking comments on an information collection extension for “Prescription Drug Marketing Act of 1987 — Administrative Procedures, Policies, and Requirements, OMB Control Number 0910-0435.” Reporting and recordkeeping requirements found in FDA regulations are intended to: **(1)** Ban the reimportation of prescription drugs produced in the U.S., except when reimported by the manufacturer or under FDA authorization for emergency medical care; **(2)** ban the sale, purchase, or trade, or the offer to sell, purchase, or trade, of any prescription drug sample; **(3)** limit the distribution of drug samples to practitioners licensed or authorized to prescribe such drugs or to pharmacies of hospitals or other healthcare entities at the request of a licensed or authorized practitioner; **(4)** require licensed or authorized practitioners to request prescription drug samples in writing; **(5)** mandate storage, handling, and recordkeeping requirements for prescription drug samples; **(6)** prohibit, with certain exceptions, the sale, purchase, or trade, or the offer to sell, purchase, or trade, of prescription drugs that were purchased by hospitals or other healthcare entities or that were donated or supplied at a reduced price to a charitable organization; and **(7)** require unauthorized wholesale distributors to provide, prior to the wholesale distribution of a prescription drug to another wholesale distributor or retail pharmacy, a statement identifying each prior sale, purchase, or trade of the drug. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-12-14/pdf/2017-26933.pdf?ref=fdaweb.com).